研究業績：英文

教室研究業績: 英文（2024年〜）

◎2026

1. Rahmi KA. Iizasa H, Yoshiyama H, Endo Y, Kageyama S, Kanai K. Ibudilast and dipyridamole ameliorate murine γ-herpesvirus 68-induced acute hepatitis following airway infection. Virus Genes (in press) https://doi.org/10.1007/s11262-026-02238-7 (IF: 1.9)
2. Liu Y, Tumurgan Z, Wai AP, Akter M, Wadi AFAA, Mizukami Y, Wada M, Okada S, Niino D, Murata T, Iizasa H*, Yoshiyama H*. SFK inhibition suppresses EBV-encoded BART miRNAs and induces apoptosis in EBV-positive gastric epithelial cells. Cancers 18(7):1082(2026) https://doi.org/10.3390/cancers18071082  (IF: 4.4) (*Corresponding author)

◎2025

1. Wada M*, Morita C, Ohsaki E, Ueda K*. Cell-intrinsic regulation of HBV RNAs by the nonsense-mediated mRNA decay pathway controls viral replication. iScience 28(5):112460(2025) https://doi.org/10.1016/j.isci.2025.112460 (IF: 4.1) (*Corresponding author)
2. Abueldahab L, Suwanmanee Y, Muriungi N, Ohsaki E, Wada M, Kimura-Ohba S, Ueda K. Analysis of the Functional Role of TIMM29 in the Hepatitis B Virus Life Cycle. Microbiol Immunol 69(4): 229-246 (2025) https://doi.org/10.1111/1348-0421.13206 (IF 1.8)
3. Morita C, Wada M, Eriko E, Kimura-Ohba S, Ueda K. Generation of Replication-Competent Hepatitis B Virus Harboring Tagged Polymerase for Visualization and Quantification of the Infection. Microbiol Immunol 69(1): 43-58 (2025) https://doi.org/10.1111/1348-0421.13183 (IF 1.8)
4. Muchtar A#, Onomura D#, Ding D, Nishitsuji H, Shimotono K, Okada S, Ueda K, Watashi K, Wakita T, Iida K, Yoshiyama H*, Iizasa H*. MicroRNA-3145 as a potential therapeutic target for hepatitis B virus: inhibition of viral replication via downregulation of HBS and HBX. Front Microbiol 15:1499216 (2025) https://doi.org/10.3389/fmicb.2024.1499216 (IF: 4.5) (#Equal contribution, *Corresponding author)
5. Wai AP, Richardo T, Wakae K, Okada S, Muramatsu M, Yoshiyama H*, Iizasa H*. Epstein-Barr virus infection induces mitochondrial DNA mutations via APOBEC3C expression in gastric epithelial cells. Microbiol Immunol 69:157-167 (2025) https://doi.org/10.1111/1348-0421.13196 (IF: 1.8)  (*Corresponding author)

◎2024

1. Kimura T, Sakata KI, Ohga N, Sato J, Itagaki T, Munekata T, Yanagawa-Matsuda A, Maeda T, Hojo M, Hatanaka KC, Hatanaka Y, Iizasa H. Salivary miRNAs as a novel therapeutic marker in a patient with advanced oral squamous cell carcinoma: A case report. Oncol Lett 29(1):52 (2024) https://doi.org/10.3892/ol.2024.14798 (IF: 2.2)
2. Nishikawa J, Fujii T, Fukuda S, Yoneda S, Tamura Y, Shimizu Y, Yanai A, Kobayashi Y, Harada K, Kawasaki K, Mishima K, Watanabe K, Mizukami Y, Yoshiyama H, Suehiro Y, Yamasaki T, Takami T. Far-ultraviolet irradiation at 222 nm destroys and sterilizes the biofilms formed by periodontitis pathogens. J Microbiol Immunol Infect 57(4):533-545 (2024) https://doi.org/10.1016/j.jmii.2024.05.005 (IF: 3.7)
3. Liu Y, Wai AP, Iida Y, Tumurgan Z, Okada S, Iizasa H^*, Yoshiyama H^*. Exploring the anti-EBV potential of suberoylanilide hydroxamic acid: leading apoptosis in infected cells by suppressing BART gene expression and inducing lytic infection. Virology 597:110161 (2024) https://doi.org/10.1016/j.virol.2024.110161 (IF: 2.4) (*Corresponding author)
4. Wadi AFAA, Onomura D, Funamori H, Khatun MM, Okada S, Iizasa H, Yoshiyama H*. Effect of strain differences, humidity changes, and saliva contamination on inactivation of SARS-CoV-2 by ions. Viruses 16(4):520 (2024) https://doi.org/10.3390/v16040520 (IF: 3.5) (*Corresponding author)